Evidence map›Paper›PMID 29594798›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2018

Improved quality of care for patients infected or colonised with ESBL-producing Enterobacteriaceae in a French teaching hospital: impact of an interventional prospective study and development of specific tools.

Véronique Mondain, Florence Lieutier, Céline Pulcini, Nicolas Degand, Luce Landraud, Raymond Ruimy, Thierry Fosse, Pierre Marie Roger

Abstract read
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Véronique MondainInfectiologie, Centre Hospitalo-Universitaire de Nice, Nice, France. mondain.v@chu-nice.fr.ORCID http://orcid.org/0000-0003-0290-2887
Florence LieutierPharmacie, Centre Hospitalo-Universitaire de Nice, Nice, France.
Céline PulciniInfectiologie, Centre Hospitalo-Universitaire de Nice, Nice, France.
Nicolas DegandBactériologie, Centre Hospitalo-Universitaire de Nice, Nice, France.
Luce LandraudBactériologie, Centre Hospitalo-Universitaire de Nice, Nice, France.
Raymond RuimyBactériologie, Centre Hospitalo-Universitaire de Nice, Nice, France.
Thierry FosseHygiène, Centre Hospitalo-Universitaire de Nice, Nice, France.
Pierre Marie RogerInfectiologie, Centre Hospitalo-Universitaire de Nice, Nice, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing incidence of ESBL-producing Enterobacteriaceae (ESBL-E) in France prompted the publication of national recommendations in 2010. Based on these, we developed a toolkit and a warning system to optimise management of ESBL-E infected or colonised patients in both community and hospital settings. The impact of this initiative on quality of care was assessed in a teaching hospital. The ESBL toolkit was developed in 2011 during multidisciplinary meetings involving a regional network of hospital, private clinic and laboratory staff in Southeastern France. It includes antibiotic treatment protocols, a check list, mail templates and a patient information sheet focusing on infection control. Upon identification of ESBL-E, the warning system involves alerting the attending physician and the infectious disease (ID) advisor, with immediate, advice-based implementation of the toolkit. The procedure and toolkit were tested in our teaching hospital. Patient management was compared before and after implementation of the toolkit over two 3-month periods (July-October 2010 and 2012). Implementation of the ESBL-E warning system and ESBL-E toolkit was tested for 87 patients in 2010 and 92 patients in 2012, resulting in improved patient management: expert advice sought and followed (16 vs 97%), information provided to the patient's general practitioner (18 vs 63%) and coding of the condition in the patient's medical file (17 vs 59%), respectively. Our multidisciplinary strategy improved quality of care for in-patients infected or colonised with ESBL-E, increasing compliance with national recommendations.

Indexed as

Cross InfectionHospitals, TeachingQuality of Health CareAnti-Bacterial Agentsbeta-Lactamasesbeta-Lactam ResistanceEnterobacteriaceaeEnterobacteriaceae InfectionsFemaleFranceHumansMaleMicrobial Sensitivity TestsProspective StudiesQuality ImprovementAnti-Bacterial Agentsbeta-Lactamases

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.